125 related articles for article (PubMed ID: 22587632)
1. iTRAQ-based proteomic profiling of breast cancer cell response to doxorubicin and TRAIL.
Leong S; Nunez AC; Lin MZ; Crossett B; Christopherson RI; Baxter RC
J Proteome Res; 2012 Jul; 11(7):3561-72. PubMed ID: 22587632
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
Leong S; McKay MJ; Christopherson RI; Baxter RC
J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146
[TBL] [Abstract][Full Text] [Related]
3. Proteome changes induced by overexpression of the p75 neurotrophin receptor (p75NTR) in breast cancer cells.
Wilmet JP; Tastet C; Desruelles E; Ziental-Gelus N; Blanckaert V; Hondermarck H; Le Bourhis X
Int J Dev Biol; 2011; 55(7-9):801-9. PubMed ID: 22161836
[TBL] [Abstract][Full Text] [Related]
4. Bik subcellular localization in response to oxidative stress induced by chemotherapy, in Two different breast cancer cell lines and a Non-tumorigenic epithelial cell line.
Trejo-Vargas A; Hernández-Mercado E; Ordóñez-Razo RM; Lazzarini R; Arenas-Aranda DJ; Gutiérrez-Ruiz MC; Königsberg M; Luna-López A
J Appl Toxicol; 2015 Nov; 35(11):1262-70. PubMed ID: 26059411
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK.
Davis T; van Niekerk G; Peres J; Prince S; Loos B; Engelbrecht AM
Biochem Pharmacol; 2018 Feb; 148():174-183. PubMed ID: 29309757
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
[TBL] [Abstract][Full Text] [Related]
7. Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
Thai le M; Labrinidis A; Hay S; Liapis V; Bouralexis S; Welldon K; Coventry BJ; Findlay DM; Evdokiou A
Cancer Res; 2006 May; 66(10):5363-70. PubMed ID: 16707463
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin Affects Expression of Proteins of Neuronal Pathways in MCF-7 Breast Cancer Cells.
Petrovic M; Simillion C; Kruzliak P; Sabo J; Heller M
Cancer Genomics Proteomics; 2015; 12(6):347-58. PubMed ID: 26543081
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
10. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
12. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
13. Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer.
Yang WS; Moon HG; Kim HS; Choi EJ; Yu MH; Noh DY; Lee C
J Proteome Res; 2012 Feb; 11(2):1078-88. PubMed ID: 22074005
[TBL] [Abstract][Full Text] [Related]
14. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
[TBL] [Abstract][Full Text] [Related]
15. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
[TBL] [Abstract][Full Text] [Related]
17. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
[TBL] [Abstract][Full Text] [Related]
18. Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry.
Leong S; Christopherson RI; Baxter RC
Cell Physiol Biochem; 2007; 20(5):579-90. PubMed ID: 17762184
[TBL] [Abstract][Full Text] [Related]
19. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
